Minireview
Krabbe Disease: Genetic Aspects and Progress toward Therapy

https://doi.org/10.1006/mgme.2000.2990Get rights and content

Abstract

Krabbe disease or globoid cell leukodystrophy is a disorder involving the white matter of the peripheral and central nervous systems. Mutations in the gene for the lysosomal enzyme galactocerebrosidase (GALC) result in low enzymatic activity and decreased ability to degrade galactolipids found almost exclusively in myelin. The pathological changes observed, including the presence of globoid cells and decreased myelin, appear to result from the toxic nature of psychosine and accumulation of galactosylceramide that cannot be degraded due to the GALC deficiency. Over 60 mutations have been identified in this gene. The great majority are disease-causing; however, a few are considered polymorphisms. While most patients present with symptoms within the first 6 months of life, others present later in life including adulthood. Even patients with the same genotype can have very different clinical presentations and course. The reason for this is not known. Treatment at this time is limited to hematopoietic stem cell transplantation that appears to slow the progression of the disease and improve the magnetic resonance images. Studies using stem cells and viral vectors to transduce transplantable cells are under way in model systems. In culture, oligodendrocytes from the twitcher mouse model can assume a normal appearance after differentiation if GALC activity is provided via viral transduction or uptake from donor cells. Therefore continued myelination and/or remyelination in patients will require supplying GALC activity by transplanted cells or viral vectors to still functional endogenous oligodendrocytes or transplantation of normal oligodendrocytes or stem cells that can differentiate into oligodendrocytes. Using the animal models these options can be explored.

References (49)

  • DA Wenger

    Krabbe disease (globoid cell leukodystrophy)

  • Wenger, D, A, Suzuki, K, Suzuki, Y, Suzuki, K, Galactosylceramide lipidosis. Globoid cell leukodystrophy (Krabbe...
  • AM Yeager et al.

    Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse

    Science

    (1984)
  • W Krivit et al.

    Hematopoietic stem-cell transplantation in globoid cell leukodystrophy

    New Engl J Med

    (1998)
  • K Krabbe

    A new familial, infantile form of diffuse brain sclerosis

    Brain

    (1916)
  • B Hagberg et al.

    Infantile globoid cell leucodystrophy (Krabbe's disease): A clinical and genetic study of 32 Swedish cases 1953–1967

    Neuropaediatrie

    (1970)
  • L Crome et al.

    Late onset globoid cell leucodystrophy

    Brain

    (1973)
  • PK Thomas et al.

    Galactosylceramide lipidosis: Novel presentation as a slowly progressive spinocerebellar degeneration

    Ann Neurol

    (1984)
  • M Vanier

    Symptomatology of late onset Krabbe's leukodystrophy: The European experience

    Dev Neurosci

    (1991)
  • P Verdu et al.

    Globoid cell leukodystrophy: A family with both late-infantile and adult type

    Neurology

    (1991)
  • EH Kolodny et al.

    Late-onset Krabbe disease (globoid cell leukodystrophy): Clinical and biochemical features of 15 cases

    Dev Neurosci

    (1991)
  • P Luzi et al.

    Multiple mutations in the GALC gene in a patient with adult-onset Krabbe disease

    Ann Neurol

    (1996)
  • J-I Satoh et al.

    Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene

    Neurology

    (1997)
  • LB Jardim et al.

    Protracted course of Krabbe disease in an adult patient bearing a novel mutation

    Arch Neurol

    (1999)
  • Cited by (180)

    • Neonatal and infantile hypotonia

      2023, Handbook of Clinical Neurology
    • Newborn screening of neuromuscular diseases

      2021, Neuromuscular Disorders
    View all citing articles on Scopus
    View full text